Toxicology specialist Harlan Laboratories is looking to tap the growing market for contract research in Oceania, signing a deal with local outfit Invenium Pharmacology to do so.
|Invenium's Anthony Bishop|
Under the agreement, Invenium will act as Harlan's agent in Southeast Asia, Australia and New Zealand, helping the CRO make its name in the region among pharma and chemical developers in need of contract services. Invenium's Anthony Bishop, a 15-year pharma vet, will lead the charge for Harlan in the area, the company said.
"There are great growth opportunities for Harlan CRS in this region," said Ciriaco Maraschiello, Harlan's director of strategic initiatives, in a statement. "Working with Anthony Bishop and Invenium Pharmacology, we can provide the expertise that companies and organizations in this region need--at a local level."
For Harlan, the partnership comes on the heels of a wealth of global expansion over the past year or so. In January, the company made a bid to grow its animal model business by opening its first breeding facility in India, and the CRO boosted its presence in Japan, South Korea, Israel and Europe in 2013. In May, the CRO invested in its U.S. operations to expand its share of the market for immunocompromised research models.
- read the statement